Fanisi Backs Sophar (Sub-Saharan Africa)

Source: Private Equity Africa

East Africa-focused private equity firm Fanisi Venture Capital Management has invested in Rwandan pharmaceutical company Sophar. The funding will allow Sophar to build a World Health Organization-certified warehouse, which will increase the company’s storage capacity from 900 products to 3,000 products. Financial details of the transaction were not disclosed.